Alterations in IL-6, IL-8, GM-CSF. TNF-α, and IFN-γ Release by Peripheral Mononuclear Cells in Patients with Active Vitiligo

The purpose of this study was to clarify the relationship between the cellular and humoral immune components in the pathogenesis of vitiligo vulgaris. By using cytokines as indicators of peripheral mononuclear cell (MNC) function, we compared the effects of phytohemagglutinin (PHA) and purified IgG on MNCs derived from patients suffering from active vitiligo with those from normal controls. The results revealed (i) a significant increase in spontaneous production of 11-6 and IL-8 in patients; (ii) PHA, purified IgG from patients (IgG-anti-MC), or IgG from normal controls (N-IgG) induced a significant increase in IL-6 but diminished GM-CSF, TNF- α , and IFN- γ release in patients; and (iii) IgG-anti-MC brought about a significantly higher stimulatory effect on IL-1 β and IFN- γ production than N-IgG in normal controls. Immunologically, IL-6 can enhance melanocyte ICAM-1 expression, which may increase leukocyte-melanocyte attachment and cause melanocyte damage in vitiligo. A decrease in GM-CSF (an intrinsic growth factor for melanocyte) production may retard recovery from vitiligo by checking the proliferation of surviving melanocytes. A significant decrease in TNF- α and IFN- γ production may partially explain the reduced inflammatory reaction in vitiliginous lesions. That IgG-anti-MC stimulates an increase in IL-1 β and IFN- γ production in controls suggests that IgG-anti-MC may play a role in melanocyte destruction mediated by monocytes.

[1]  G. Imokawa,et al.  Granulocyte/macrophage colony-stimulating factor is an intrinsic keratinocyte-derived growth factor for human melanocytes in UVA-induced melanosis. , 1996, The Biochemical journal.

[2]  A. Al-Fouzan,et al.  STUDY OF HLA CLASS I/II AND T LYMPHOCYTE SUBSETS IN KUWAITI VITILIGO PATIENTS , 1995, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[3]  L. Hegedüs,et al.  High frequency of thyroid dysfunction in patients with vitiligo. , 1994, Acta dermato-venereologica.

[4]  C. Yu,et al.  Coexistence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo. , 1993, The Journal of investigative dermatology.

[5]  S. Im,et al.  PERIPHERAL BLOOD LYMPHOCYTE IMBALANCE IN KOREANS WITH ACTIVE VITILIGO , 1993, International journal of dermatology.

[6]  R. B. Goudie,et al.  Abnormal expression of MHC class II and ICAM‐1 by melanocytes in vitiligo , 1993, The Journal of pathology.

[7]  J. Morelli,et al.  Influence of inflammatory mediators and cytokines on human melanocyte function. , 1993, The Journal of investigative dermatology.

[8]  M. Waheed,et al.  In vitro assessment of 'T' lymphocyte functioning in vitiligo. Support for autoimmune hypothesis concerning the disease. , 1992, Acta Dermato-Venereologica.

[9]  A. Cattaneo,et al.  Plasma α-melanocyte-stimulating hormone, β-endorphin, met-enkephalin, and natural killer cell activity in vitiligo , 1992 .

[10]  W. Ludwig,et al.  NONSEGMENTAL VITILIGO: DECREASE OF THE CD45RA+ T‐CELL SUBSET AND EVIDENCE EOR PERIPHERAL T‐CELL ACTIVATION , 1992, International journal of dermatology.

[11]  T. Luger,et al.  Modulation of intercellular adhesion molecule-1 expression on human melanocytes and melanoma cells: evidence for a regulatory role of IL-6, IL-7, TNF beta, and UVB light. , 1992, The Journal of investigative dermatology.

[12]  D. Norris,et al.  Cytokine modulation of adhesion molecules in the regulation of immunologic cytotoxicity of epidermal targets. , 1990, The Journal of investigative dermatology.

[13]  D. Norris,et al.  Modulation of melanocyte intercellular adhesion molecule-1 by immune cytokines. , 1990, The Journal of investigative dermatology.

[14]  A. Fattorossi,et al.  Peripheral T-cell subset imbalance in patients with vitiligo and in their apparently healthy first-degree relatives. , 1990, Annals of allergy.

[15]  H. Yu,et al.  Depletion and Repopulation of Langerhans Cells in Nonsegmental Type Vitiligo , 1990, The Journal of dermatology.

[16]  F. Fraschini,et al.  T cell subpopulations in vitiligo: a chronobiologic study. , 1990, Journal of the American Academy of Dermatology.

[17]  K. Tracey,et al.  Peptide Regulatory Factors CACHECTIN/TUMOUR NECROSIS FACTOR , 1989, The Lancet.

[18]  M. Mantovani,et al.  Circadian rhythm of natural killer cell activity in vitiligo. , 1989, Journal of the American Academy of Dermatology.

[19]  E. Appella,et al.  The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. , 1989, Science.

[20]  C. Yu,et al.  Alteration of mitogenic responses of mononuclear cells by anti-ds DNA antibodies resembling immune disorders in patients with systemic lupus erythematosus. , 1989, Scandinavian journal of rheumatology.

[21]  C. Yu,et al.  Defective helper T cell function in IgM rheumatoid factor synthesis in patients with ankylosing spondylitis. , 1989, Scandinavian journal of rheumatology.

[22]  K. Manogue,et al.  Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. , 1988, Science.

[23]  J. Bystryn,et al.  Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity. , 1988, The Journal of investigative dermatology.

[24]  K. Matsushima,et al.  Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1). , 1987, Journal of immunology.

[25]  E. Martz,et al.  LFA-1 and other accessory molecules functioning in adhesions of T and B lymphocytes. , 1987, Human immunology.

[26]  A. P. Kelly,et al.  T cell profiles in vitiligo. , 1986, Journal of the American Academy of Dermatology.

[27]  A. Tosti,et al.  Prevalence of autoimmune atrophic gastritis in vitiligo. , 1986, Digestion.

[28]  J. Lacour,et al.  Vitiligo: peripheral T‐cell subset imbalance as defined by monoclonal antibodies , 1985, The British journal of dermatology.

[29]  G. Trinchieri,et al.  Immune interferon: a pleiotropic lymphokine with multiple effects. , 1985, Immunology today.

[30]  A. Peserico,et al.  Incidence and significance of organ-specific autoimmune disorders (clinical, latent or only autoantibodies) in patients with vitiligo. , 1985, Dermatologica.

[31]  G. Naughton,et al.  Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation. , 1983, The Journal of investigative dermatology.

[32]  G. Naughton,et al.  Antibodies to normal human melanocytes in vitiligo , 1983, The Journal of experimental medicine.

[33]  J. Nordlund,et al.  Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo. , 1982, The Journal of investigative dermatology.

[34]  C. Cassimos,et al.  Autoimmunity and vitiligo. , 1978, Archives of dermatology.

[35]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[36]  C. J. Stevenson,et al.  VITILIGO, THYROID DISEASE AND AUTOIMMUNITY , 1968, The British journal of dermatology.